| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.084 | 0.6 |